CM
AZN icon

Caption Management’s AstraZeneca AZN Stock Holding History

Caption Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.6M Buy
+34,800
New +$6.55M 0.03% 510
2026
Q1 		– Sell
-88,950
Closed -$17.2M – 1560
2025
Q4 		$16.4M Buy
88,950
+46,500
+110% +$8.16M 0.11% 221
2025
Q3 		$6.51M Buy
42,450
+14,451
+52% +$2.19M 0.05% 397
2025
Q2 		$3.91M Buy
+27,999
New +$3.92M 0.04% 473
2024
Q3 		– Sell
-3,150
Closed -$508K – 1275
2024
Q2 		$491K Buy
+3,150
New +$474K 0.01% 812
2024
Q1 		– Sell
-750
Closed -$101K – 1203
2023
Q4 		$101K Sell
750
-17,250
-96% -$2.24M ﹤0.01% 1176
2023
Q3 		$2.44M Buy
18,000
+17,989
+163,536% +$2.46M 0.04% 528
2023
Q2 		$1.5K Sell
11
-13,489
-100% -$1.98M ﹤0.01% 1053
2023
Q1 		$1.87M Sell
13,500
-19,600
-59% -$2.64M 0.04% 455
2022
Q4 		$4.49M Buy
33,100
+26,567
+407% +$3.33M 0.07% 327
2022
Q3 		$716K Sell
6,533
-4,467
-41% -$567K 0.01% 976
2022
Q2 		$1.45M Buy
+11,000
New +$1.44M 0.02% 752
2022
Q1 		– Sell
-78,650
Closed -$9.43M – 1459
2021
Q4 		$9.16M Buy
78,650
+69,494
+759% +$8.18M 0.1% 258
2021
Q3 		$1.1M Sell
9,156
-90,894
-91% -$10.6M 0.01% 995
2021
Q2 		$12M Buy
100,050
+53,720
+116% +$5.89M 0.16% 159
2021
Q1 		$4.61M Buy
46,330
+38,830
+518% +$3.9M 0.1% 265
2020
Q4 		$750K Buy
+7,500
New +$794K 0.02% 665
2020
Q3 		– Sell
-50,975
Closed -$5.39M – 1031
2020
Q2 		$5.39M Buy
+50,975
New +$5.26M 0.18% 154

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Caption Management's AZN Position: Q2 2026 in Review

Caption Management opened a new position in AstraZeneca (AZN) in Q2 2026: 34,800 shares worth $6.6M. The stake represents 0.03% of the portfolio and ranks #510 among its holdings. This is a return to the name: Caption Management previously reported a position in AZN as recently as Q4 2025.

Caption Management first reported a position in AZN in Q2 2020 and has held it in 18 quarters since. The position peaked at $16.4M in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Caption Management held 34,800 shares of AstraZeneca worth $6.6M as of Q2 2026.
  • AstraZeneca was a new Caption Management position in Q2 2026.
  • AstraZeneca made up 0.03% of Caption Management's portfolio in Q2 2026, its #510 holding.
  • Caption Management first reported a position in AstraZeneca in Q2 2020 and has held it in 18 quarters since.
  • Caption Management's AstraZeneca position peaked at $16.4M in Q4 2025.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.